3
Announcements
Trials
Browse
Landscape
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Thoracic
1
Other solid neoplasm
1
Gynecologic
1
Gastrointestinal
1
Conditions
Ovarian Neoplasms
31
Peritoneal Neoplasms
28
Fallopian Tube Neoplasms
14
Stomach Neoplasms
13
Carcinoma, Ovarian Epithelial
13
Colorectal Neoplasms
11
Appendiceal Neoplasms
5
Neoplasm Metastasis
4
Uterine Neoplasms
3
Recurrence
3
Neoplasms
3
Uterine Cervical Neoplasms
2
Pseudomyxoma Peritonei
2
Pancreatic Neoplasms
2
Mesothelioma, Malignant
2
Mesothelioma
2
Colonic Neoplasms
2
Carcinoma
2
Sarcoma
1
Rhabdomyosarcoma
1
Rectal Neoplasms
1
Pleural Effusion
1
Peritoneal Diseases
1
Pelvic Neoplasms
1
Ovarian Epithelial Cancer Recurrent
1
Ovarian Cancer Recurrent
1
Liposarcoma
1
Krukenberg Tumor
1
Hyperthermia
1
Gastrointestinal Neoplasms
1
Interventions
pembrolizumab
3
Trastuzumab
3
Paclitaxel
2
Oxaliplatin
2
Nivolumab
2
Interleukin-12 Subunit p35
2
Cisplatin
2
Carboplatin
2
trastuzumab deruxtecan
1
tivozanib
1
tipifarnib
1
seribantumab
1
pertuzumab
1
motexafin lutetium
1
lenvatinib
1
entinostat
1
atezolizumab
1
Specimen Handling
1
Peripheral Blood Stem Cell Transplantation
1
Ondansetron
1
Mesna
1
Magnetic Resonance Spectroscopy
1
Leucovorin
1
Irinotecan
1
Ipilimumab
1
Interleukin-12
1
Injections
1
Immunohistochemistry
1
Ifosfamide
1
Hyperthermic Intraperitoneal Chemotherapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Gallbladder Neoplasms
×
Hyperthermic Intraperitoneal Chemotherapy
×
Gynecologic
×
Clear all
NCT03210298
2019-10-08
PIPACRegis
University of Magdeburg
Unknown
1,000 enrolled